Similar articles

• [On the association of various neoplastic hemopathies in the same patient: clinical contribution].

  Storti E, Mauri G, Artusi T, Traldi A, Vaccari GL. Storti E, et al. Rev Clin Esp. 1966 Sep 30;102(6):477-89. Rev Clin Esp. 1966. PMID: 4870554 Spanish. No abstract available.
• The effect of Milurit on secondary hyperuricaemia following cytostatic treatment in haemoblastosis patients.

  Bodrogi I, Bálint I. Bodrogi I, et al. Ther Hung. 1979;27(2):77-83. Ther Hung. 1979. PMID: 494144 No abstract available.
• [Ambulatory endoxan therapy by high doses].

  Fischer M, Martin H, Schubert JC. Fischer M, et al. Dtsch Med Wochenschr. 1967 Jun 23;92(25):1145-50. doi: 10.1055/s-0028-1103755. Dtsch Med Wochenschr. 1967. PMID: 5338225 German. No abstract available.
• [Pathogenesis of immunologic deficiency diseases associated with lymphoproliferative disorders].

  Ponzone A, Tarocco RP, Nicola P. Ponzone A, et al. Minerva Pediatr. 1970 Dec 22;22(51):2542-60. Minerva Pediatr. 1970. PMID: 4993895 Review. Italian. No abstract available.
• [Danger of hyperuricemia in the treatment of acute leukemia, lymphosarcoma and reticulosarcoma].

  Armata J. Armata J. Pol Tyg Lek. 1974 Jun 10;29(23):1005-6. Pol Tyg Lek. 1974. PMID: 4601064 Review. Polish. No abstract available.